INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. ...
February 27 2019 - 2:24PM
Business Wire
The Schall Law Firm, a national shareholder rights litigation
firm, announces the filing of a class action lawsuit against AVEO
Pharmaceuticals, Inc. (“AVEO” or “the Company”) (NASDAQ: AVEO) for
violations of §§10(b) and 20(a) of the Securities Exchange Act of
1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities
and Exchange Commission.
Investors who purchased the Company's shares between August 4,
2016 and January 31, 2019, inclusive (the “Class Period”), are
encouraged to contact the firm before April 26, 2019.
If you are a shareholder who suffered a loss, click here to
participate.
We also encourage you to contact Brian Schall, or Sherin
Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite
404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights
free of charge. You can also reach us through the firm's website
at www.schallfirm.com, or by email
at brian@schallfirm.com.
The class, in this case, has not yet been certified, and until
certification occurs, you are not represented by an attorney. If
you choose to take no action, you can remain an absent class
member.
According to the Complaint, the Company made false and
misleading statements to the market. The 2013 TIVO-3 trial for
AVEO’s lead candidate drug, tivozanib, was not adequately designed
to address concerns about survivability. The drug did not have
sufficient survival data to gain FDA approval after its initial
rejection. The lack of survival data put the Company at risk for
additional FDA approval delays. Based on these facts, the Company’s
public statements were false and materially misleading throughout
the class period. When the market learned the truth about AVEO,
investors suffered damages.
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and
specializes in securities class action lawsuits and shareholder
rights litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and rules of
ethics.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190227005829/en/
The Schall Law FirmBrian Schall, Esq.,Sherin Mahdavian,
Esq.,www.schallfirm.comOffice: 310-301-3335Cell:
424-303-1964info@schallfirm.com
AVEO Pharmaceuticals (NASDAQ:AVEO)
Historical Stock Chart
From Sep 2024 to Oct 2024
AVEO Pharmaceuticals (NASDAQ:AVEO)
Historical Stock Chart
From Oct 2023 to Oct 2024